Emerging Pharmaceutical Markets in Latin America - New Market Research Report

This report examines Argentina, Chile, Colombia, Peru, and Venezuala in terms of their attractiveness as pharmaceutical markets and outsourcing destinations. Healthcare systems, government initiatives, intellectual property, and pricing are examined. The report presents results of a survey of 301 industry exectives and builds an attractiveness index, based on 4 dimensions to compare the countries.

Features and benefits

• Gain insights into the relative merits of Latin American markets from a survey of 301 executives.
• Learn about regional variations in IP protection, infrastructure, and disease burden.
• Evaluate pricing and reimbursement environments across the region.
• Forecast pharma market growth to 2016 for 5 markets.
• Analyze each country as a potential outsourcing destination.

Highlights

All five markets are poised for strong growth in the five years to 2016, with their forecast compound annual growth rates (CAGRs) ranging from 8.9% in Colombia to 20.8% in Venezuela. Factors driving this growth include improved eocnomic performance, an ageing population, stricter quality controls, rising prices and increased public sector coverage.

Although the majority of respondents to Business Insights' survey are planning to expand their presence in Latin America in the next ten years, distribution (rather than manufacturing or research & development) is the main focus of their expansion plans.

Domestic companies from the region concentrate mainly on generics and non-bioequivalent "similares", and have shown little interest in original R&D. For those with ambitions to expand, their expansion strategies are based mainly on building up their operations in other Latin America countries.

Request a Sample and get your copy of the report @ http://www.reportsnreports.com/reports/144088-emerging-pharmaceutical-markets-in-latin-america.html